Article Details
Retrieved on: 2021-09-27 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In July 2021, iBio added three new antibody programs to its oncology drug discovery pipeline ... and middle-down characterization for monoclonal antibodies.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here